Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 3Terminated 1Recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Neoplasm Metastasis 25Leukemia, Myeloid, Acute 25Breast Neoplasms 18Prostatic Neoplasms 16Myelodysplastic Syndromes 15Lymphoma, Large B-Cell, Diffuse 15Leukemia, Lymphocytic, Chronic, B-Cell 15Multiple Myeloma 14Lung Neoplasms 13Precursor Cell Lymphoblastic Leukemia-Lymphoma 12Colorectal Neoplasms 12Carcinoma, Non-Small-Cell Lung 12Triple Negative Breast Neoplasms 11Pancreatic Neoplasms 11Burkitt Lymphoma 11Neoplasms 9Lymphoma, Mantle-Cell 9Leukemia, Myelomonocytic, Chronic 9Ovarian Neoplasms 8Melanoma 8Stomach Neoplasms 7Lymphoma, T-Cell 7Squamous Cell Carcinoma of Head and Neck 6Lymphoma, B-Cell 6Carcinoma, Renal Cell 6Myeloproliferative Disorders 5Mouth Neoplasms 5Lymphoma 5Leukemia, Biphenotypic, Acute 5Fallopian Tube Neoplasms 5

Interventions

Specimen Handling 6Tamoxifen 3Starch 1Standard of Care 1Sentinel Lymph Node Biopsy 1Restraint, Physical 1Radiotherapy 1Radiosurgery 1Probiotics 1Practice Guidelines as Topic 1Omacor 1Methods 1Mastectomy, Subcutaneous 1Laser Therapy 1Genetic Testing 1Follow-Up Studies 1Diet Therapy 1Diet 1Chromatin Immunoprecipitation Sequencing 1Cannabidiol 1Bone Density 1Biopsy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Breast Carcinoma In Situ × Biopsy × Clear all
NCT06184750 2026-05-13

Finding the Best Tamoxifen Dose for Breast Cancer Risk Reduction in Premenopausal Women, RENAISSANCE Trial

National Cancer Institute (NCI)

Phase 2 Recruiting
200 enrolled
Breast

Breast Carcinoma In Situ, Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating

Data powered by HemOnc (CC BY 4.0) Colophon âš¡